{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:23:14Z","timestamp":1793852594192,"version":"4.6.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>A narrative expert review aiming to summarize the clinical epidemiology and management of critically ill patients with malignant hyperthermia (MH).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>Medline searches were conducted to identify relevant articles describing the epidemiology, pathophysiology, and management of MH. Guidelines from key MH organizations were also incorporated into this review.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>STUDY SELECTION:<\/jats:title>\n            <jats:p>Relevant studies regarding MH in both ICU and perioperative settings were reviewed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA EXTRACTION:<\/jats:title>\n            <jats:p>Data from relevant studies were summarized and qualitatively assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SYNTHESIS:<\/jats:title>\n            <jats:p>MH is a severe reaction triggered by inhalational volatile anesthetics and succinylcholine in genetically susceptible patients. The condition is characterized by an early onset (min to hr) rise in temperature, hypercarbia, and muscular rigidity following exposure to triggering medications with potential complications of coagulopathy, rhabdomyolysis, and acute kidney injury. Acute management necessitates a coordinated multidisciplinary team approach with specific management using dantrolene, active cooling, and hyperventilation. A suspected MH reaction has important implications for future anesthetic exposure for both the patient and their family. All suspected reactions should be followed up at a specialized MH testing center using muscle contracture and genetic testing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Increasing use of inhalational anesthetics in the ICU underscores the need for enhanced education on the diagnosis and management of MH to ensure optimal patient sedation care and safety.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000006401","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T02:55:57Z","timestamp":1724381757000},"page":"1934-1940","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":29,"title":["Malignant Hyperthermia"],"prefix":"10.1097","volume":"52","author":[{"given":"Teeda","family":"Pinyavat","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Columbia University, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Riazi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University Health Network, Toronto, ON, Canada."},{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Deng","sequence":"additional","affiliation":[{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Slessarev","sequence":"additional","affiliation":[{"name":"Department of Medicine, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Cuthbertson","sequence":"additional","affiliation":[{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada."},{"name":"Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada."},{"name":"Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada."},{"name":"Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Ibarra Moreno","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University Health Network, Toronto, ON, Canada."},{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Jerath","sequence":"additional","affiliation":[{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada."},{"name":"Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada."},{"name":"Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada."},{"name":"Department of Anesthesia, Sunnybrook Health Sciences Centre, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"e1050","DOI":"10.1097\/CCE.0000000000001050","article-title":"Inhaled volatiles for status asthmaticus, epilepsy, and difficult sedation in adult ICU and PICU: A systematic review.","volume":"6","author":"Gorsky","year":"2024","journal-title":"Crit Care Explor"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1164\/rccm.201512-2435CP","article-title":"Volatile anesthetics. Is a new player emerging in critical care sedation?","volume":"193","author":"Jerath","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/ALN.0000000000004994","article-title":"Volatile anesthetic sedation for critically ill patients.","volume":"141","author":"O\u2019Gara","year":"2024","journal-title":"Anesthesiology"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bjae.2023.12.004","article-title":"Sedation with volatile anaesthetics in intensive care.","volume":"24","author":"Jabaudon","year":"2024","journal-title":"BJA Educ"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bja.2023.05.004","article-title":"Effect of inhaled anaesthetics on cognitive and psychiatric outcomes in critically ill adults: A systematic review and meta-analysis.","volume":"131","author":"Cuninghame","year":"2023","journal-title":"Br J Anaesth"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S2213-2600(21)00323-4","article-title":"Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: An open-label, phase 3, randomised controlled, non-inferiority trial.","volume":"9","author":"Meiser","year":"2021","journal-title":"Lancet Respir Med"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1213\/ANE.0000000000001634","article-title":"Safety and efficacy of volatile anesthetic agents compared with standard intravenous midazolam\/propofol sedation in ventilated critical care patients: A meta-analysis and systematic review of prospective trials.","volume":"124","author":"Jerath","year":"2017","journal-title":"Anesth Analg"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1164\/rccm.201604-0686OC","article-title":"Sevoflurane for sedation in acute respiratory distress syndrome. A randomized controlled pilot study.","volume":"195","author":"Jabaudon","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12630-014-0270-2","article-title":"The introduction of a lightweight mini vaporizer and malignant hyperthermia.","volume":"62","author":"Rosenberg","year":"2015","journal-title":"Can J Anaesth"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/ALN.0b013e3182a8a8e7","article-title":"Using exome data to identify malignant hyperthermia susceptibility mutations.","volume":"119","author":"Gonsalves","year":"2013","journal-title":"Anesthesiology"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jclinane.2017.03.016","article-title":"Prevalence of malignant hyperthermia diagnosis in hospital discharge records in California, Florida, New York, and Wisconsin.","volume":"39","author":"Lu","year":"2017","journal-title":"J Clin Anesth"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/ALN.0000000000002813","article-title":"An assessment of penetrance and clinical expression of malignant hyperthermia in individuals carrying diagnostic ryanodine receptor 1 gene mutations.","volume":"131","author":"Ibarra Moreno","year":"2019","journal-title":"Anesthesiology"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1186\/cc8145","article-title":"Incidence of propofol-related infusion syndrome in critically ill adults: A prospective, multicenter study.","volume":"13","author":"Roberts","year":"2009","journal-title":"Crit Care"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: A review.","volume":"10","author":"Rosenberg","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1213\/ANE.0b013e3182768f99","article-title":"Case report: Death in the emergency department: An unrecognized awake malignant hyperthermia-like reaction in a six-year-old.","volume":"116","author":"Lavezzi","year":"2013","journal-title":"Anesth Analg"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s12630-019-01320-z","article-title":"Fatal awake malignant hyperthermia episodes in a family with malignant hyperthermia susceptibility: A case series.","volume":"66","author":"Zvaritch","year":"2019","journal-title":"Can J Anaesth"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.nmd.2013.03.008","article-title":"Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis.","volume":"23","author":"Dlamini","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/ALN.0000000000000732","article-title":"Malignant hyperthermia testing in probands without adverse anesthetic reaction.","volume":"123","author":"Timmins","year":"2015","journal-title":"Anesthesiology"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1213\/ANE.0000000000000062","article-title":"Anesthetic drugs and onset of malignant hyperthermia.","volume":"118","author":"Visoiu","year":"2014","journal-title":"Anesth Analg"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","article-title":"Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.","volume":"110","author":"Larach","year":"2010","journal-title":"Anesth Analg"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2110-5820-3-8","article-title":"An observational study on rhabdomyolysis in the intensive care unit. Exploring its risk factors and main complication: Acute kidney injury.","volume":"3","author":"El-Abdellati","year":"2013","journal-title":"Ann Intensive Care"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/anae.14407","article-title":"The use of charcoal filters in malignant hyperthermia: Have they found their place?","volume":"74","author":"Bilmen","year":"2019","journal-title":"Anaesthesia"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bja.2020.04.089","article-title":"Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines.","volume":"125","author":"Glahn","year":"2020","journal-title":"Br J Anaesth"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1213\/ANE.0000000000004039","article-title":"Consensus statement of the Malignant Hyperthermia Association of the United States on unresolved clinical questions concerning the management of patients with malignant hyperthermia.","volume":"128","author":"Litman","year":"2019","journal-title":"Anesth Analg"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/01.anes.0000265148.86566.68","article-title":"Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions.","volume":"106","author":"Burkman","year":"2007","journal-title":"Anesthesiology"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1213\/XAA.0000000000000147","article-title":"Implications of national anesthesia workload on the staffing of a call center: The malignant hyperthermia consultant hotline.","volume":"5","author":"Dexter","year":"2015","journal-title":"A A Case Rep"},{"key":"R29-20250502"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bja\/aev225","article-title":"European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility.","volume":"115","author":"Hopkins","year":"2015","journal-title":"Br J Anaesth"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.bja.2018.06.028","article-title":"Genetic epidemiology of malignant hyperthermia in the UK.","volume":"121","author":"Miller","year":"2018","journal-title":"Br J Anaesth"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/ALN.0000000000001878","article-title":"Malignant hyperthermia in the post-genomics era: New perspectives on an old concept.","volume":"128","author":"Riazi","year":"2018","journal-title":"Anesthesiology"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T18:01:39Z","timestamp":1746208899000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006401","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]}}}